"The shifts in the financial markets, international forces and the 2008 election will have enormous impact on the future of new technology in healthcare. The Medical Innovation Summit provides unrivaled insights, exceptional networking and actionable takeaways for anyone who cares about medical innovation."
- Tim Ring, CR Bard
CEOS of GE, Johnson & Johnson, Eli Lilly, Abbott, AstraZeneca, Amgen, Boston
Scientific, 3M, Medtronic and Edwards Lifesciences; partners from top venture
firms, heads of Government agencies and top clinicians.
IN MEMORIAM
Andrew C. Novick, MD
1948 - 2008
|
| Cleveland, Ohio | InterContinental Hotel & Bank of America Conference Center |
Past Summits
|
2005 LIST OF SPEAKERS:
- Jeffrey Binder, President,
Abbott Spine, Vice President, Abbott
- Arthur Collins, CEO, Medtronic
- Sheryl Conley, President, Global
Products Group, Zimmer
- Michael Dormer, Worldwide Chairman,
Medical Devices, Johnson & Johnson
- Steven Ek, COO, Arthrosurface
- Newt Gingrich, Former Speaker,
U.S. House of Representatives
- Scott Gottlieb, M.D., Deputy
Commissioner for Medical and Scientific Affairs, U.S. Food and
Drug Administration
- Steven Healy, President & CEO,
Disc Dynamics
- Gary Henley, President, Orthofix,
Inc.
- Joseph Hogan, CEO, GE Healthcare
Technologies
- Alan Kaganov, Sc.D., Partner,
U.S. Venture Partners
- James Kuras, Senior Vice President
& CTO, Axiomed
- Helmut Link, Managing Director,
Waldermar Link
- Mark LoGuidice, CEO, Spine
Wave
- Stephen MacMillan, CEO, Stryker
- Eric Major, President & CEO,
K2M
- Dane Miller, Ph.D., CEO, Biomet
- Jeffrey
Miller, Vice President of Health and Life Sciences
Industries, Hewlett-Packard Company
- Thomas Miller, President, Siemens
Medical Solutions Health Services
- Michael Mogul, President, Stryker
Orthopaedics
- Richard Mott, CEO, Kyphon
- Sir Christopher O'Donnell,
CEO, Smith & Nephew
- Patricia Perry, General Manager,
Digital Health Group, Intel
- Michael Porter, Ph.D., Harvard
Business School
- Richard Randall, CEO, TranS1
- Harry Rein, General Partner,
Foundation Medical Partners
- F. David Rollo, M.D., Ph.D.,
Chief Medical Officer, Philips Medical Systems
- Kevin Sidow, CEO, St. Francis
Medical Technologies
- Dave Stassen, Managing Director,
Split Rock Partners
- Karen Talmadge, Ph.D. Co-Founder,
CSO & EVP, Kyphon
- Stephen Ubl, CEO, AdvaMed
- Bess Weatherman, Partner, Warburg
Pincus
2005 AGENDA:
| Monday,
October 24, 2005 |
| 1:00 - 8:00 P.M. |
Registration |
| 2:00 P.M. |
Exhibits Open - Light Refreshments
2nd and 3rd Floors |
| 4:00 - 4:05 P.M. |
A. Malachi Mixon III
Chairman & CEO, Invacare
Chairman of the Board of Trustees
The Cleveland Clinic
Welcome |
| 4:05 - 4:15 P.M. |
Delos M. Cosgrove, M.D.
CEO & President
The Cleveland Clinic
Innovation and The Cleveland Clinic |
| 4:15 - 5:15 P.M. |
Newt Gingrich
Former Speaker of the U.S. House of Representatives
The Promise and Challenge of Medical Innovation
Medical innovation will provide true added value, only
if we can also transform our current health system. This
talk proposes and defines an “intelligent health system”
that improves health outcomes and the quality of life, leads
to longer lives at lower costs, saves individuals, companies
and governments billions of dollars. |
| 5:15 - 6:05 P.M. |
Michael E. Porter, Ph.D.
Bishop William Lawrence University Professor
Harvard Business School
Redefining Health Care: Creating Value-Based
Competition on Results
To date, the participants in the health care system have
competed at the wrong level – among health plans,
networks, and hospitals – and on the wrong things.
This presentation outlines a framework for creating health
care competition based on patient value, which will require
new strategies and operating practices for hospitals, physician
practices and technology suppliers. |
| 6:05 - 6:20 P.M. |
Arthur D. Collins, Jr.
Chairman & CEO, Medtronic, Inc.
Chairman, AdvaMed
Looking Ahead in the Medical Technology Industry
Mr. Collins will provide his unique perspective, as Chairman
of AdvaMed, on the challenges facing the orthopaedic industry. |
| 7:00 - 10:30 P.M. |
Opening Reception, Dinner and Entertainment
House of Blues
The Blues Brothers Band |
Tuesday,
October 25, 2005 |
| 6:30 A.M – 2:00 P.M. |
Registration |
| 6:30 – 7:30 A.M. |
Continental Breakfast |
| 7:00 A.M. - 7:00 P.M. |
Exhibits Open
2nd and 3rd Floors |
| 7:30 A.M. |
Welcome |
| 7:30 – 9:00 A.M. |
Live Spine Surgeries
Moderated by Edward C. Benzel, M.D.
Chairman, Cleveland Clinic Spine Institute
The Cleveland Clinic
Innovation in Practice: New Minimally Invasive
Spinal Surgeries |
| 9:00 – 9:45 A.M. |
Sir Christopher O’Donnell
Chief Executive
Smith & Nephew
Orthopaedic Innovation – A Global Perspective
Orthopaedic innovation arises from many sources - surgeons,
engineers and countries around the world. Effective innovation
requires high technology insights combined with effective
economics to create both value and patient benefit. Learn
about key international innovations in orthopaedics that
deliver value to patients and to global health care systems.
|
| 9:45 – 10:30 A.M. |
Break |
| 10:30 – 11:15 A.M. |
Stephen P. MacMillan
President & CEO
Stryker
Enhancing the Patient Experience via Innovation
A focus on the unique interconnectivity that surgeons,
hospitals and medical device companies have in enhancing
health care and meeting the expectations of patients. What
is the value of medical technology and how it can be leveraged
by all parties who are involved with today’s health
care system? |
| 11:15 A.M. – 12:00 P.M. |
Michael F. DeMane
Senior Vice President and Vice President Europe, Canada,
Latin America and Emerging Markets
Medtronic
Spinal Innovations: Game-Changing Technologies
Compelling advances in the orthopaedic spinal market will
enhance patient care in the coming years. |
| 12:00 – 1:30 P.M. |
Lunch
Michael J. Dormer
Worldwide Chairman, Medical Devices Group
Johnson & Johnson
History and Future of the Orthopaedics Marketplace
In the complex health care environment of the future, technology
innovation alone will not drive standards of care. The orthopaedics
industry will need to build expertise in public policy,
outcomes research and patient advocacy in order to demonstrate
the full value of its technologies in improving the standard
of care and quality of life. |
| 1:40– 3:10 P.M. |
Moderated by Gordon R. Bell, M.D.
Vice Chairman, Cleveland Clinic Spine Institute,
Vice Chairman, Department of Orthopaedic Surgery
The Cleveland Clinic
- Edward C. Benzel, M.D., Chairman, Cleveland Clinic Spine
Institute, The Cleveland Clinic
- Jeffrey R. Binder, President, Abbott Spine, Vice President,
Abbott
- James M. Kuras, Senior Vice President & CTO, Axiomed
- Isador H. Lieberman, M.D., FRCS(C), Director of Minimally
Invasive Surgery Center, The Cleveland Clinic
- Helmut D. Link, Managing Director, Waldemar Link, GmbH
- Eric D. Major, President & CEO, K2M
- Richard W. Mott, President & CEO, Kyphon
- Richard D. Randall, President & CEO, TranS1
New Spine Technologies
Leading innovators in spine technologies describe and debate
opportunities and challenges of bringing new spine innovations
that change the face of spinal surgery, from bench to bedside.
|
| 3:15 – 3:40 P.M. |
Break |
| 3:40– 4:40 P.M. |
Moderated by Christopher M. Coburn
Executive Director, CCF Innovations
The Cleveland Clinic
- Paul E. DiCorleto, Ph.D., Chairman, Lerner Research
Institute, The Cleveland Clinic
- Michael Fonstein, Ph.D., CEO & President, Cleveland
BioLabs
- R. K. Khosla, CEO & President, Peritec Biosciences
- William C. Mulligan, Chairman, CCFI Industrial Advisory
Board; Primus Venture Partners
- Mark R. Willig, President & CEO, PrognostiX
- Jay S. Yadav, Chairman, CCF Innovations; Cardiovascular
Medicine, The Cleveland Clinic
Commercializing Cleveland Clinic Technology
The Cleveland Clinic has a long history of innovation with
a growing portfolio of market-important IP. This panel will
describe the importance of commercialization to the Clinic,
the opportunity for outside investors, the quality and breadth
of research at the Clinic, and how the commercialization
system integrates researchers, innovators, investors, and
patient needs. |
| 4:40 – 6:10 P.M. |
Moderated by Jonathan L. Schaffer, M.D.
Advanced Orthopaedic Technology Group
Orthopaedic Research Center
The Cleveland Clinic
- Sheryl L. Conley, President, Global Products Group,
Zimmer
- Fred B. Dinger, President & CEO, OsteoBiologics,
Inc.
- Steven W. Ek, Executive Vice President and Chief Operating
Officer, Arthrosurface
- Gary D. Henley, President, Orthofix, Inc.
- Joseph P. Iannotti, M.D., Ph.D., Chairman, Department
of Orthopaedic Surgery, The Cleveland Clinic
- Viktor E. Krebs, M.D., Head, Section of Adult Reconstructive
Surgery, Department of Orthopaedic Surgery, The Cleveland
Clinic
- Dane A. Miller, Ph.D., President & CEO, Biomet
- Michael P. Mogul, President, Stryker Orthopaedics
New Joint Technologies
This panel of leading innovators and joint surgeons will
present and debate what’s new and hot in joint technologies
today, what will we see over the next five to ten years,
and the challenges to making these innovations a successful
reality for companies, hospitals and society. |
| 6:10 – 7:00 P.M. |
Welcome Reception |
| 7:00 P.M. |
Dinner
Sponsored by Norman Noble/Electrolizing
Stephen J. Ubl
President & CEO
AdvaMed
Federal Policy Trends and Their Impact on the
Orthopaedic Industry
An update on the national dynamics, trends and issues around
orthopaedic innovation and medical devices regulation: product
approval and clearance, reimbursement, and access to international
markets.
Scott Gottlieb, M.D.
Deputy Commissioner for Medical and Scientific Affairs
U.S. Food and Drug Administration
FDA Commissioner’s Office Strategies
to Speed the Flow of Safe and Effective Innovations in the
U.S.
What new strategies will the FDA use to improve the speed
and lower the cost to get higher quality innovations from
bench to bedside in a more timely and cost-effective manner?
What new post-market regulations or changes can we expect
from the FDA? |
Wednesday,
October 26, 2005 |
| 6:30 – 9:00 A.M. |
Registration |
| 6:30 – 7:30 A.M. |
Continental Breakfast |
| 7:00 A.M. - 2:00 P.M. |
Exhibits Open
2nd and 3rd Floors |
| 7:30 – 9:00 A.M. |
Live Joint Surgeries
Moderated by Peter J. Evans, M.D., Ph.D.
Head, Section of Hand & Upper Extremity Surgery
Department of Orthopaedic Surgery
The Cleveland Clinic
Innovation in Practice: New Minimally Invasive
Joint Surgeries |
| 9:00– 10:45 A.M. |
Moderated by Harry T. Rein
General Partner
Foundation Medical Partners
- Steven J. Healy, President & CEO, Disc Dynamics
- Alan L. Kaganov, Sc.D., Partner, U.S. Venture Partners
- Mark D. LoGuidice, Chairman & CEO, Spine Wave
- Kevin K. Sidow, President & CEO, St. Francis Medical
Technologies
- David W. Stassen, Managing Director, Split Rock Partners
- Karen D. Talmadge, Ph.D., Co-Founder, CSO & EVP,
Kyphon
- Elizabeth H. Weatherman, Partner, Warburg Pincus
Venture Capital and Orthopaedics
Venture Capital is a critical resource for bringing orthopaedic
innovations from bench to bedside. Health care industry
venture capitalists discuss their rationale for backing
innovative firms, while company executives explain the unique
aspects of venture capital and commercialization in the
orthopaedics market, including special challenges and new
financing approaches. |
| 10:45– 11:15 A.M. |
Break |
| 11:15 A.M. – 12:30 P.M. |
Moderated by Michael T. Modic, M.D.
Chairman, Division of Radiology
The Cleveland Clinic
- C. Martin Harris, M.D., Chief Information Officer, The
Cleveland Clinic
- Jeffrey D. Miller, Vice President of Health and Life
Sciences Industries, Hewlett-Packard Company
- Thomas J. Miller, President, Siemens Medical Solutions
Health Services
- Patricia Perry, General Manager, Digital Health Group,
Intel
- F. David Rollo, M.D., Ph.D., Chief Medical Officer,
Philips Medical Systems
Comprehensive System Integration vs. Best in
Breed
Which goal is more productive and effective: system integration
or best in breed innovation? |
| 12:30– 1:50 P.M. |
Lunch
Joseph M. Hogan
President & CEO
GE Healthcare
Orthopaedic Challenges and Opportunities:
Perspectives from the Fortune 5
As a Fortune 5 employer, a leading global supplier of medical
devices and a player in multiple industries that are converging
to provide even higher quality orthopaedic medical innovations,
GE is in a prime position to understand and give perspective
on changing market demand, global regulatory and legal requirements
and convergence opportunities. |
| 1:50– 2:00 P.M. |
Jay S. Yadav, M.D.
Chairman, CCF Innovations
Cardiovascular Medicine
The Cleveland Clinic
Wrap Up |
|
|
|
